Literature DB >> 6370002

Drug sensitivity and isoenzyme type in cloned lines of Plasmodium falciparum.

P M Graves, R Carter, J S Keystone, D C Seeley.   

Abstract

Clones have been derived by limiting dilution from recent isolates of Plasmodium falciparum from Africa and Brazil. These clones have been characterized for pyrimethamine and chloroquine sensitivity and/or isoenzyme type. Clones obtained from an isolate containing a mixture of GPI isoenzyme types were found to have (with one exception) only GPI-1 or GPI-2. Clones differing 1,000-fold in pyrimethamine resistance were derived from a single isolate from Brazil which was resistant to both pyrimethamine and chloroquine. Several levels of chloroquine sensitivity were observed in the isolates studied. All clones showed levels of chloroquine sensitivity similar to that of their parent isolates. The KZ1 isolate from East Africa had an intermediate level of chloroquine resistance and a flat dose-response curve and each of its clones had a similar dose-response curve, indicating that the intermediate level of chloroquine resistance did not result from the KZ1 isolate's being a mixture of clones with high and low sensitivity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6370002     DOI: 10.4269/ajtmh.1984.33.212

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

1.  Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.

Authors:  A Singh; P J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development.

Authors:  D L Doolan; A J Saul; M F Good
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

Review 3.  Strain theory of malaria: the first 50 years.

Authors:  F Ellis McKenzie; David L Smith; Wendy P O'Meara; Eleanor M Riley
Journal:  Adv Parasitol       Date:  2008       Impact factor: 3.870

4.  Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria.

Authors:  D S Peterson; D Walliker; T E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Mechanism of pyrimethamine resistance in recent isolates of Plasmodium falciparum.

Authors:  T F McCutchan; J A Welsh; J B Dame; I A Quakyi; P M Graves; J C Drake; C J Allegra
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

6.  Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro.

Authors:  C F Ockenhouse; C Magowan; J D Chulay
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

7.  Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.

Authors:  D S Peterson; W K Milhous; T E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

8.  Effects of transmission-blocking monoclonal antibodies on different isolates of Plasmodium falciparum.

Authors:  P M Graves; R Carter; T R Burkot; J Rener; D C Kaushal; J L Williams
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

9.  Antigenic variation of parasite-derived antigens on the surface of Babesia bovis-infected erythrocytes.

Authors:  D R Allred; R M Cinque; T J Lane; K P Ahrens
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

10.  clag9: A cytoadherence gene in Plasmodium falciparum essential for binding of parasitized erythrocytes to CD36.

Authors:  K R Trenholme; D L Gardiner; D C Holt; E A Thomas; A F Cowman; D J Kemp
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.